SS
INDV icon

SBI Securities’s Indivior Pharmaceuticals INDV Stock Holding History

SBI Securities’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
269
+19
+8% +$689 ﹤0.01% 1779
2026
Q1 		$7.62K Hold
250
– – ﹤0.01% 1851
2025
Q4 		$8.97K Hold
250
– – ﹤0.01% 1759
2025
Q3 		$6.03K Buy
+250
New +$5.23K ﹤0.01% 1971

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's INDV Position: Q2 2026 in Review

SBI Securities increased its Indivior Pharmaceuticals (INDV) stake by 7.6% in Q2 2026, buying an estimated $689 and bringing the position to 269 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

SBI Securities first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • SBI Securities held 269 shares of Indivior Pharmaceuticals worth $11K as of Q2 2026.
  • SBI Securities bought 19 Indivior Pharmaceuticals shares in Q2 2026, an estimated $689.
  • Indivior Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1779 holding.
  • SBI Securities first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.